FDA Inspection 1002433 — Pfizer, Inc.
The FDA completed an inspection of Pfizer, Inc. on Jan 12, 2017 in Groton, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 12, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Groton, CT (United States)
Additional Details
Sponsor, Contract Research Organization